The Parvovirus B19 IgG/IgM test is used to diagnose infection caused by this virus. Parvovirus B19 is the causative agent of common illnesses such as “fifth disease”, which is characterized by a facial rash. The test works by measuring IgM and IgG antibodies in the blood:
IgM is produced in the early stages of infection (1–2 weeks after exposure) and indicates an active or recent infection.
IgG appears later and usually reflects past exposure or immunity.
This test is typically performed using methods like ELISA, and is especially important in certain clinical situations such as:
Pregnancy (due to the risk of fetal transmission and complications like severe anemia),
Immunocompromised patients,
Individuals with hematologic disorders (e.g., aplastic crisis in patients with sickle cell anemia).
Interpreting the results depends on the timing of sample collection and the combination of antibodies:
Positive IgM (with or without IgG) suggests a recent infection.
Positive IgG and negative IgM usually indicates past infection and immunity.
Negative IgG and IgM may suggest no prior exposure.
This test should be interpreted alongside clinical symptoms and other investigations to reach a definitive diagnosis.